VEXAS Syndrome Clinical Features and Treatment Outcomes in a Chinese Cohort of 16 Patients
Small study links UBA1 gene variants to blood and inflammatory issues in China
This retrospective cohort study of 16 Chinese patients describes main clinical features and treatment responses in VEXAS syndrome. Constitut…
A specific genetic change called a UBA1 variant was found in 81 percent of patients in China with blood disorders and inflammation affecting…
Gender-affirming hormone and puberty blocker use increased in Norway from 2008 to 2022
Norway saw increased use of gender-affirming hormones and blockers since 2015
A nationwide register-based study in Norway from 2008 to 2022 found that incidence of gender incongruence diagnoses and prevalence of gender…
Since 2015, more teens in Norway received gender-affirming hormones and puberty blockers, while diagnoses for gastrointestinal issues also r…